# Treatment and Prognosis of Patients With Chronic HBV Infection

> **NCT05392387** · — · RECRUITING · sponsor: **Xiangya Hospital of Central South University** · enrollment: 500 (estimated)

## Conditions studied

- Hepatitis B Virus Infection

## Interventions

- **OTHER:** Standard antiviral therapy

## Key facts

- **NCT ID:** NCT05392387
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-25
- **Primary completion:** 2024-10-25
- **Final completion:** 2026-10-25
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05392387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05392387, "Treatment and Prognosis of Patients With Chronic HBV Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05392387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*